| 000 | 01130 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250517181200.0 | ||
| 264 | 0 | _c20181228 | |
| 008 | 201812s 0 0 eng d | ||
| 022 | _a1537-6613 | ||
| 024 | 7 |
_a10.1093/infdis/jix351 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAdimora, Adaora A | |
| 245 | 0 | 0 |
_aImplementing National HIV/AIDS Strategy 2015 Treatment Targets Is Cost-effective and Would Save Lives: What Other Evidence Do We Need? _h[electronic resource] |
| 260 |
_bThe Journal of infectious diseases _c10 2017 |
||
| 300 |
_a787-789 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _xeconomics |
| 650 | 0 | 4 |
_aContinuity of Patient Care _xeconomics |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV _xphysiology |
| 650 | 0 | 4 |
_aHIV Infections _xeconomics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aUnited States _xepidemiology |
| 773 | 0 |
_tThe Journal of infectious diseases _gvol. 216 _gno. 7 _gp. 787-789 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/infdis/jix351 _zAvailable from publisher's website |
| 999 |
_c27682011 _d27682011 |
||